OXALIPLATIN, FLUOROURACIL, ERLOTINIB HYDROCHLORIDE, AND RADIATION THERAPY BEFORE SURGERY AND ERLOTINIB HYDROCHLORIDE AFTER SURGERY IN TREATING PATIENTS WITH LOCALLY ADVANCED CANCER OF THE ESOPHAGUS OR GASTROESOPHAGEAL JUNCTION: